Read Gene

Read Gene ROE

The Return on Equity (ROE) of Read Gene (RDG.WA) as of Sep 21, 2026 is 3.87 %. In the previous year, Return on Equity (ROE) was 0.70 % — a change of 453.28% (higher).

ROE

3.87 %

YoY

453.28%

Last updated:

In 2026, Read Gene's return on equity (ROE) was 3.87 %, a 453.28% increase from the 0.70 % ROE in the previous year.

The Read Gene ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2016
-16.59 PLN
Jan 1, 2017
-1.83 PLN
Jan 1, 2018
24.91 PLN
Jan 1, 2019
-2.36 PLN
Jan 1, 2020
8.60 PLN
Jan 1, 2021
0.70 PLN
Jan 1, 2022
3.87 PLN
The Read Gene ROE history
YEARROEYoY
3.87 %+453.28%
0.70 %-91.87%
8.60 %-464.32%
-2.36 %-109.48%
24.91 %-1,457.76%
-1.83 %-88.94%
-16.59 %—
Access this data via the Eulerpool API
Get Free API Key

Read Gene Stock analysis

What does Read Gene do? Read Gene is one of the most popular companies on Eulerpool.

ROE Details

Decoding Read Gene's Return on Equity (ROE)

Read Gene's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Read Gene's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Read Gene's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Read Gene’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Read Gene stock

Return on Equity (ROE) of Read Gene is 3.87 % in 2026.

Return on Equity (ROE) of Read Gene changed from 0.70 % to 3.87 %, representing a 453.28% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Read Gene since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Read Gene with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API
Get Free API Key

Profitability — Read Gene

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Read Gene